Changmao (Dalian) New Material Company Limited, a wholly-owned subsidiary of Changmao Biochemical Engineering Co. Ltd., has entered into a significant sale and leaseback arrangement. On 30 June 2025, Changmao Dalian and its Lessor signed the Sale and Leaseback Agreements, which involve transferring the Leased Assets to the Lessor. This transaction is part of a major financial initiative by the parent company, aimed at optimizing its asset management strategy. The arrangement includes several agreements, such as a finance lease agreement and an ownership transfer agreement. The parent company, Changmao Biochemical Engineering Co. Ltd., is a joint stock limited company incorporated in the People's Republic of China and is publicly listed on the Main Board of the Stock Exchange of Hong Kong.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.